Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 12, 2006, Pages 1462-1471

  Haeckel, Rainer ^a   Raber, Rüdiger ^a   Wosniok, Werner ^b  

^a KLINIKUM BREMEN MITTE   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

Early diagnosis of type 2 diabetes; Glucose tolerance test; Insulin sensitivity index

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; BODY MASS; CAPILLARY BLOOD; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VENOUS BLOOD; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; FEMALE; GERMANY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PLASMA; PREVALENCE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION;

EID: 33845707874     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.272     Document Type: Article

References (47)

1. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
3. Schianca GPC, Rossi A, Sainghi PP, Maduli E, Bartoli E. The significance of impaired glucose tolerance. Diabetes Care 2003;26:1333-7.
4. Davies MJ, Raymond NT, Day JL, Hales CN, Burden AC. Impaired glucose tolerance and the fasting hyperglycaemia have different characteristics. Diabet Med 2000;17:433-40.
5. Hanefeld M, Koehler C, Fuecker K, Henkel E, Shaper F, Temelkova-Kurktschiev T. Insulin secretion in isolated impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2003;26:868-74.
6. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 1988;319:1500-6.
7. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002;136:575-81.
8. Haeckel R, Wosniok W, Raber R, Janka HU. Detecting type 2 diabetes by a single post-challenge blood sample. Clin Chem Lab Med 2003;41:1251-8.
9. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.
10. Hosmer DW, Lemeshow ST. Applied logistic regression, 2nd ed. New York: John Wiley & Sons, 2000:1-382.
11. Cederholm J, Wibell L. Evaluation of insulin release and relative peripheral resistance with use of the oral glucose tolerance test. Scand J Clin Lab Invest 1985;45:741-55.
12. Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1990;10:167-75.
13. Haeckel R, Raber R, Wosniok W. Comparability of indices for insulin resistance and insulin sensitivity determined during oral glucose tolerance tests. Clin Chem Lab Med 2006;44:817-23.
14. Santner TJ, Duffy DE. A note on A. Altert and J. Anderson's condition for the existence of maximum likelihood estimation in logistic regression models. Biometrika 1986;73:755-8.
15. Kairisto V, Poola A. Software for illustrative presentation of basic clinical characteristics of laboratory tests. Scand J Lab Invest 1995;55(Suppl 222):43-60.
16. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall, 1993.
17. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983;21:709-20.
18. Haeckel R, Colic D, Wosniok W. Reference interval of serum insulin concentration. Clin Chem Lab Med 2003;42:1069-70.
19. Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 1994;17:152-4.
20. Godsland IF, Jeffs JA, Fohnston DG. Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 2004;47:1157-66.
21. Bartoli E, Castello L, Sainaghi PP, Schianca GP. Progression from hidden to overt type 2 diabetes mellitus. Clin Lab 2005;51:613-24.
22. Kallner A, Waldenström J. Does the uncertainty of commonly performed glucose measurements allow identification of individuals at high risk for diabetes? Clin Chem Lab Med 1993;37:907-12.
23. Stahl M, Brandslund I, Joergensen LG, Hylthoft Petersen P, Borch-Johnsen K, de Fine Olivarius N. Can capillary whole blood and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus? Scand J Clin Lab Invest 2002;62:159-66.
24. Haeckel R, Brinck U, Colic D, Janka HU, Püntmann I, Schneider J, et al. Comparability of blood glucose concentrations measured in different sample systems for detecting glucose intolerance. Clin Chem 2002;48:936-9.
25. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102-10.
26. Weyer Ch, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-94.
27. Piché ME, Arcand-Bossé JF, Desprès JP, Pérusse L, Lemieux S, Weisnagel SJ. What is a normal glucose value? Diabetes Care 2004;27:2470-7.
28. The DECODE study group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003;26:688-96.
29. Stern MP, Rosenthal M, Haffner SM. A new concept of impaired glucose tolerance: relation to cardiovascular risk. Arteriosclerosis 1985;5:311-4.
30. Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Eposito K, Giugliano D. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 2004;53:701-10.
31. Heine RJ, Dekker JM. Beyond postprandial hyperglycaemia: metabolic factors associated with cardiac vascular disease. Diabetes Care 2002;45:461-75.
32. Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes 2003;52:2867-73.
33. Schousboe K, Henriksen JE, Kyvik KO, Soerensen TI, Hylthoft Petersen P. Reproducibility of S-insulin and B-glucose responses in two identical glucose tolerance tests. Scand J Clin Invest 2002;62:623-30.
34. Qiao Q, Eriksson J, Jousilahti P, Tuomilehto J. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 2003;26:2910-4.
35. Rathman W, Haastert B, Icks A, Löwel H, Meisinger C, Holle R, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening, The KORA survey 2000. Diabetologia 2003;46:182-9.
36. Ricos C, Caia F, Garcia-Lario JV, Hernandez A, Iglesias N, Jimenez CV, et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004;64:175-84.
37. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebowitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomiletho J, Zimmet P, the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.
38. Galton F. Regression towards mediocrity in hereditary stature. J Anthropol Inst 1885;15:246-65.
39. Haeckel R, Wosniok W. The phenomenon of regression-towards-the-mean. Clin Chem Lab Med 2004;42:241-2.
40. Joergensen LG, Stahl M, Brandslund I, Hylthoft Petersen P, Borch-Johnson K, de Fine Olivarius N. Plasma glucose reference interval in a low-risk population. 2. Impact of the new WHO and ADA recommendations on the diagnosis of diabetes mellitus. Scand L Clin Lab Invest 2001;61:181-90.
41. Rihl J, Biermann E, Standl E. Insulin resistance and type 2 diabetes: the IRIS study. Diabetes Stoffwechsel 2002;11:150-8.
42. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Surveys. J Am Med Assoc 2002;287:356-9.
43. Tuomiletho J. A glucose tolerance test is important for clinical practice. Diabetes Care 2002;25:1880-2.
44. Chan AY, Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989;35:315-7.
45. Burrin JM, Alberti KG. What is blood glucose. Can it be measured? Diabet Med 1990;7:199-206.
46. Morrison B, Fleck A. Plasma or whole blood glucose? Clin Chim Acta 1873;45:293-7.
47. Rainey PM. Monitoring blood glucose meters. Am J Clin Pathol 1995;103:125-6.